The drugs, delivered intravenously and made by Regeneron Pharmaceuticals and Eli Lily, have concentrated doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk for severe symptoms or having to be hospitalized.
from Michigan expands antibody treatment to cut hospitalizations
https://ift.tt/32gi7IM
https://ift.tt/eA8V8J
No comments:
Post a Comment